WO2013167742A1 - Rapidly disintegrating monolayer film and use thereof in oral hygiene - Google Patents

Rapidly disintegrating monolayer film and use thereof in oral hygiene Download PDF

Info

Publication number
WO2013167742A1
WO2013167742A1 PCT/EP2013/059748 EP2013059748W WO2013167742A1 WO 2013167742 A1 WO2013167742 A1 WO 2013167742A1 EP 2013059748 W EP2013059748 W EP 2013059748W WO 2013167742 A1 WO2013167742 A1 WO 2013167742A1
Authority
WO
WIPO (PCT)
Prior art keywords
green tea
essential oil
hydroxypropylcellulose
film
tea extract
Prior art date
Application number
PCT/EP2013/059748
Other languages
French (fr)
Inventor
Michel Sournac
Isabel Ribeiro Dos Santos
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of WO2013167742A1 publication Critical patent/WO2013167742A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063Periodont
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/79Fixation, conservation, or encapsulation of flavouring agents in the form of films
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/594Mixtures of polymers

Definitions

  • the present invention relates to novel fast-disintegrating monolayer films for oral administration of a pharmaceutical composition, based on parsley essential oil and green tea extract and containing water-soluble polymers, and as their uses.
  • the film disintegrates in the oral cavity and releases the active substances.
  • Halitosis (or bad breath) is a common pathology that can have significant psychological effects, such as self-depreciation, isolation, depression, besides these social impacts, it is dangerous for the health of teeth and even for general health.
  • halitosis The main origin of halitosis is oral in about 85% of cases.
  • the other etiologies are digestive, in the esophagus (diverticula, stenosis, megaoesophagia), stomach (stenosis, gastroparesis, gastritis); pulmonary (food or drug), or even metabolic (ketoacidosis, renal or hepatic insufficiency).
  • the main cause of the oral origin is bacterial.
  • Some bacteria such as Porphyromonas, Prevotella, Fusobacterium present on the dental surfaces, in the periodontal pockets, on the dorsal part of the tongue, in the presence of food debris of amino acids, and according to the pH (an alkaline salivary pH favors the halitosis) release volatile compounds driven outwardly by exhaled air.
  • These Volatile compounds have a strong odor, very uncomfortable at extremely low concentrations.
  • These are essentially sulfur derivatives and amino derivatives. Among the sulfur derivatives are present essentially:
  • Proteins, diamines (putrescine, cadaverine) are also involved in bad breath.
  • Volatile sulfur derivatives are detectable by a "human nose" from the concentration of a few tens of ppb.
  • Hydrogen sulfide has a destructive effect on the tissues exposed to it, leading to apoptotic death of periodontal cells. Moreover, it accelerates the proliferation of bone-destructive cells (osteoclasts) that can be concretely translated into bone resorption problems leading to periodontal disease or loosening. A vicious circle then engages because loosening is a common cause of halitosis. Hydrogen sulfide is also harmful to pulp cells, a recent study (Kobayashi et al., 2011, Journal of Endodontics, vol 37 (4): 4479-4484) shows that this hydrogen sulphide profoundly affects the metabolism of mitochondrial membranes of cells of the dental pulp causing apoptotic cell death.
  • the pulp Located in a cavity in the center of the tooth, the pulp is however not isolated from the outside because exchanges occur permanently through the dentine, porous tissue, and the enamel that behaves as a selective membrane. Hydrogen sulfide penetrates and diffuses through the hard tissue of the tooth to affect its vitality. This phenomenon could explain the appearance of pulpites or acute inflammation of the nerve of the tooth. In case of pulpitis, the devitalization (removal of the nerve) of the tooth is the only solution.
  • Parsley and green tea are known for their antimicrobial properties. According to a study by Lodhia et al., 2008 (J. Nutr.Sci./ Vitaminol 54, 89-94), green tea makes it possible to reduce the concentration of sulfur compounds. in the mouth breath. Similarly, the antibacterial and anti-infectious activities of the parsley essential oil have been described (El-Megeed Hashem and Farahat Sahab, 1999, Food Chemistry 65, 29-33). For example, according to patent EP 1053743 the combination of olive oil and parsley oil was claimed and according to the patent application WO 2008/068408 it is claimed the combination of parsley essential oil and green tea extract, in the treatment of halitosis.
  • composition according to this application concern the quantities (expressed by weight relative to the total weight of the composition) of essential oil of parsley (0.01% to 5%) and green tea (0.005% to 1%) and the composition according to this invention is preferably a cooked sugar or a lozenge to be sucked.
  • Fast-disintegrating films must respond to often contradictory conditions: they must have a binding character that allows them to be shaped and, secondly, have an almost instant disintegration capability. They must also present sufficient flexibility and resistance, but also some stability necessary for normal storage conditions. These qualities are essential for their packaging in sachets, blisters or dispenser boxes.
  • the currently used soluble films consist mainly of hydrophilic polymers having film-forming properties, and whose thickness and specific surface area make it possible to envisage rapid disintegration in contact with saliva.
  • hydrophilic film-forming polymers are most often glucans, natural gums, or povidone derivatives.
  • the combination of at least two polymers is generally desired in order to find a compromise between the main characteristics of the film, ie the flexibility, the mechanical strength and the speed of disintegration.
  • the combination of at least two water-soluble cellulosic polymers is often necessary.
  • Those comprising the combination of water-soluble cellulosic polymers of high molecular weight (60,000 to 150,000 Da) and water-soluble cellulosic polymers of low molecular weight are most often encountered.
  • the first type of polymer makes it possible to adjust the mechanical properties of the film, while the second type of polymer makes it possible to vary the disintegration time.
  • International Application WO 05/039499 discloses a fast disintegrating pharmaceutical or cosmetic film formulation consisting of a combination of hydroxypropylcellulose (Klucel JF®) and hydroxypropylmethylcellulose (Methocel® grades E, E50, E4M and SGA16M).
  • the films described in this application each contain many plasticizers (polyalcohols, sorbitan ester, citric acid esters, etc.) which are necessary for obtaining flexible films and which make the formulation complex.
  • glucan polymers such as pullulans are theoretically capable of forming fast disintegrating films because of their high solubility, rapid dissolution rate and taste properties.
  • their low molecular weight is a drawback which has the consequence of not facilitating the formation of films for concentrations of less than 20%; indeed, under these conditions, the viscosity of the mixtures is low and makes them take a risk with respect to the homogeneity of the latter, when, for example, an insoluble filler (active ingredient in dispersion) is added to the mixture. It is therefore necessary to associate pullulans with other natural polymers such as carrageenates or certain gums.
  • the application WO 03/030881 describes a preparation, in the form of an edible film preferably comprising a glucan and a water-soluble polymer, in a ratio of between 40: 1 and 0.5: 1.
  • This water-soluble polymer is characterized by a molecular weight This makes it possible to increase the naturally low viscosity of the pullulans and to stabilize the mixture when it comprises a suspension of active principle.
  • this polymer is a polysaccharide or a natural gum, forming part of alginates, carrageenates, hydroxypropylmethylcellulose, locust bean gum, guar gum, xanthan gum, dextrans, gum arabic, gellan gum, alone or in combination.
  • compositions described in this application contain anti ⁇ agents foams, necessary for obtaining films free of air bubbles. It is also possible to associate the cellulosic polymers with natural polymers such as carrageenates or certain gums.
  • the international application WO 04/105758 describes a ternary polymeric preparation, in the form of fast release edible film containing triprolidine for the treatment of sleep disorders, and comprising xanthan gum, hydroxypropyl methylcellulose and carrageenan. .
  • Natural gums guar gum, locust bean gum, xanthan gum, alginates and carrageenans
  • polyvinyl pyrrolidone are often considered as stabilizing polymers, which must be added to either cellulose derivatives or glucans to enable the production of movies. These conditions are not always satisfactory, which also leads to the use of the addition of a plasticizer compound, such as polyoxyethylenated esters of sorbitan, esters of fatty acids and glycerol, glycerol, acid esters.
  • a plasticizer compound such as polyoxyethylenated esters of sorbitan, esters of fatty acids and glycerol, glycerol, acid esters.
  • the concentration of cellulosic polymer is between 20 and 75% by weight.
  • Other non-cellulosic polymers can also be used, such as polyvinyl pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, polyethylene glycol, natural gums such as xanthan gum, gum tragacanth, guar gum acacia gum, gum arabic, water-dispersible polyacrylates such as polyacrylic acid, methylmethacrylate copolymer, carboxyvinyl copolymers.
  • the international application WO 04/087084 describes a preparation, in the form of a fast release edible film composed of cellulosic film-forming polymers, more particularly of a mixture of high-viscosity polymers and low-viscosity polymers present at low concentration, which presents an economic advantage.
  • the cellulosic polymers are of the hydroxypropyl methylcellulose type, preferably the Methocel®, K-series or E-series products, and more specifically the K4M, K100, K3, E50 and E4M grades.
  • the presence of plasticizing agents, in proportions ranging from 0.01% to 30%, is necessary to obtain flexible and non-brittle films.
  • the international application WO 04/045537 describes a complex preparation in the form of an edible film intended for the treatment of pharyngitis, consisting of pullulans, guar gum, pectins, xanthan gum, alginates, of gelatin, starches, modified starches, maltodextrins, gluten, carboxymethylcellulose, locust bean gum, carrageenates.
  • the film comprises a polymeric mixture of a hydrophilic film-forming agent consisting of a copolymer of polyvinyl alcohol and polyethylene glycol, an active substance and a hydrophilic gelling agent.
  • the object of the present invention is to provide novel fast disintegrating monolayer films based on green tea extract and parsley essential oil, as described below and illustrated in the examples, whose matrix is constituted essentially two water-soluble polymers.
  • fast-disintegrating film flexible galenic forms having a thickness of less than 100 microns and whose disintegration, dissolution, dispersion or decomposition time in the oral cavity remains less than one minute, advantageously less than 30 seconds and even more advantageously from 10 to 20 seconds.
  • the active substances contained in this film can thus be absorbed by passage of the oral mucosa or sublingual or by swallowing.
  • the amounts of green tea extract in the composition are expressed by weight of dry extract of green tea relative to the total weight of said composition.
  • parsley essential oil is intended to mean the essential oil obtained from leaves and / or stalks of parsley.
  • the amount of green tea extract is between 1 and 15%, more preferably between 8 and 12% and even more preferably is equal to 10%.
  • the amount of parsley essential oil is between 0.05 and 1%, more advantageously between 0.1 and 0.4% and even more advantageously is equal to 0.3%.
  • the present invention thus relates to a monolayer film with rapid disintegration for the oral administration of a composition based on green tea extract and parsley essential oil, characterized in that it comprises a mixture of water-soluble polymers, d an emulsifier, and at least one plasticizer.
  • the mixture of water-soluble polymers consists of sodium carboxymethylcellulose and hydroxypropylcellulose.
  • the weight ratio of sodium carboxymethylcellulose and hydroxypropylcellulose is between 2 and 10, more advantageously this ratio is between 3 and 5 and even more advantageously this ratio is equal to 4.
  • the plasticizer makes it possible to increase the flexibility of the films, for example polyols, sorbitan esters or citric acid esters.
  • the plasticizers can be added directly to the formulation during the manufacture of the films.
  • Suitable plasticizers include polyethylene glycol, such as Lutrol E400, polyethylene oxide, polyoxamers, polyvinyl alcohol, or mixtures of these polymers; triacetin, glycerol, mannitol, xylitol and other polyols well known to those skilled in the art. Sorbitol and glycerol are particularly well suited.
  • the amounts of plasticizers in the present invention are between 0.5 and 10% by weight of the dry film, and more particularly between 2 and 4%.
  • the homogeneous mixture further contains additional components such as one or more emulsifier (s) and / or a plurality of filler (s).
  • the preferred emulsifiers are sugar esters, which the skilled person knows well.
  • the preferred emulsifier is sucrose stearate.
  • polysorbate 80 also called "tween 80”
  • polyethylene glycol at 4% did not make the mixture sufficiently homogeneous at the concentrations tested, revealing the technical difficulty to obtain an adequate formulation .
  • Tween 80 at 1% as an emulsifier is responsible for the presence on the films of the phenomenon of "fish eyes", this emulsifier has not allowed to improve the result.
  • the filler may be chosen from the mineral fillers conventionally used, such as silica, talc or other silicate, titanium dioxide, but also from certain pharmaceutical diluents or lubricants such as magnesium stearates, calcium stearates, or zinc.
  • flavors and / or sweeteners may be added to the film formulation to improve the palatability of the films.
  • Aromas and sweeteners can be added during the production of films. They can be natural or artificial, they are well known to those skilled in the art. The choice of flavors and / or sweeteners is not important for the invention.
  • the invention also relates to the use of an oral hygiene composition in the form of a fast disintegrating monolayer film comprising a green tea extract, parsley essential oil, a mixture of water-soluble polymers, an emulsifier, and less a plasticizer for the preparation of a medicament for preventing and / or treating halitosis.
  • Example 1 The invention will now be illustrated by way of non-limiting example by the following examples. These examples particularly highlight the difficulty of developing the composition.
  • Example 1 The invention will now be illustrated by way of non-limiting example by the following examples. These examples particularly highlight the difficulty of developing the composition.
  • ES TV dry extract of green tea
  • AP pea starch
  • CMC carboxymethylcellulose
  • HPC hydroxypropyl methylcellulose
  • MC methylcellulose
  • P pectin
  • PVP polyvinylpyrrolidone
  • the characteristics of the film namely its transparency, its flexibility, its resistance, whether it is noisy or not, if it is sticky, elastic have been evaluated. Other parameters such as grammage, disintegration time, maximum force and elongation at break have also been quantified.
  • concentrations of sorbitol in the presence or absence of titanium dioxide were evaluated by also varying the ratios between sodium carboxymethylcellulose and hydroxypropylcellulose.
  • EXAMPLE 4 Examples of Compositions According to the Invention Unit Composition of a Disintegrating Film (Table 3).
  • Chlorophylline cupro sodium 0, 10 0.2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to novel rapidly disintegrating monolayer films intended for the oral administration of a pharmaceutical composition, based on essential oil of parsley and on extract of green tea and containing water-soluble polymers, and also to the uses thereof.

Description

FILM MONOCOUCHE A DESINTEGRATION RAPIDE ET SON UTILISATION FAST DISINTEGRATING MONOLAYER FILM AND USE THEREOF
DANS L'HYGIENE BUCCALE La présente invention concerne de nouveaux films monocouche à désintégration rapide destinés à l'administration buccale d'une composition pharmaceutique, à base d'huile essentielle de persil et d'extrait de thé vert et contenant des polymères hydrosolubles , ainsi que leurs utilisations. The present invention relates to novel fast-disintegrating monolayer films for oral administration of a pharmaceutical composition, based on parsley essential oil and green tea extract and containing water-soluble polymers, and as their uses.
Lors de l'administration, le film se délite dans la cavité buccale et libère les substances actives.  During administration, the film disintegrates in the oral cavity and releases the active substances.
L'halitose (ou mauvaise haleine) est une pathologie fréquente qui peut avoir des effets psychologiques non négligeables, comme 1 ' autodépréciation, l'isolement, la dépression, à côté de ces impacts sociaux, elle se révèle dangereuse pour la santé des dents et même pour la santé générale .  Halitosis (or bad breath) is a common pathology that can have significant psychological effects, such as self-depreciation, isolation, depression, besides these social impacts, it is dangerous for the health of teeth and even for general health.
L'origine principale de l'halitose est buccale dans environ 85% des cas. Les autre étiologies sont digestives, au niveau de l'œsophage (diverticules, sténoses, mégaoesophagie) , de l'estomac (sténoses, gastroparésie, gastrite) ; pulmonaires (alimentaires ou médicamenteuses), ou bien encore métaboliques (acidocétose, insuffisance rénale ou hépatique) .  The main origin of halitosis is oral in about 85% of cases. The other etiologies are digestive, in the esophagus (diverticula, stenosis, megaoesophagia), stomach (stenosis, gastroparesis, gastritis); pulmonary (food or drug), or even metabolic (ketoacidosis, renal or hepatic insufficiency).
La cause principale de l'origine buccale est bactérienne. Certaines bactéries telles que Porphyromonas, Prevotella, Fusobacterium présentes sur les surfaces dentaires, dans les poches parodontales , sur la partie dorsale de la langue, en présence de débris alimentaires d'acides aminés, et en fonction du pH (un pH salivaire alcalin favorise l'halitose) libèrent des composés volatiles entraînés vers l'extérieur par l'air expiré. Ces composés volatiles présentent une odeur forte, très désagréable à des concentrations extrêmement faibles. Ce sont essentiellement des dérivés soufrés et des dérivés aminés. Parmi les dérivés soufrés sont présents essentiellement : The main cause of the oral origin is bacterial. Some bacteria such as Porphyromonas, Prevotella, Fusobacterium present on the dental surfaces, in the periodontal pockets, on the dorsal part of the tongue, in the presence of food debris of amino acids, and according to the pH (an alkaline salivary pH favors the halitosis) release volatile compounds driven outwardly by exhaled air. These Volatile compounds have a strong odor, very uncomfortable at extremely low concentrations. These are essentially sulfur derivatives and amino derivatives. Among the sulfur derivatives are present essentially:
- l'hydrogène sulfuré H2S hydrogen sulphide H 2 S
- le métylmercaptan CH3SH - the metyl mercaptan CH 3 SH
- le dimétylmercaptan (CH3)2S. dimethyl mercaptan (CH 3 ) 2 S.
Des protéines, les diamines (putrescine, cadavérine) sont également impliquées dans la mauvaise haleine.  Proteins, diamines (putrescine, cadaverine) are also involved in bad breath.
Les dérivés soufrés volatiles sont détectables par un « nez humain » dès la concentration de quelques dizaines de ppb.  Volatile sulfur derivatives are detectable by a "human nose" from the concentration of a few tens of ppb.
L'hydrogène sulfuré a un effet destructeur sur les tissus qui lui sont exposés, entraînant la mort des cellules parodontales par apoptose. Par ailleurs il accélère la prolifération des cellules destructrices de l'os (ostéoclastes ) pouvant se traduire concrètement par des problèmes de résorption osseuse conduisant à la maladie parodontale ou déchaussement. Un cercle vicieux s'enclenche alors car le déchaussement est une cause fréquente d'halitose. L'hydrogène sulfuré est également nocif pour les cellules pulpaires, une étude récente (Kobayashi et al., 2011, Journal of Endodontics, vol 37 (4) : 4479-4484) montre que cet hydrogène sulfuré affecte profondément le métabolisme des membranes mitochondriales des cellules de la pulpe dentaire provoquant la mort cellulaire par apoptose. Située dans une cavité au centre de la dent, la pulpe n'est cependant pas isolée de l'extérieur car des échanges se produisent en permanence à travers la dentine, tissu poreux, et l'émail qui se comporte en membrane sélective. L'hydrogène sulfuré pénètre et diffuse à travers les tissus durs de la dent pour affecter sa vitalité. Ce phénomène pourrait expliquer l'apparition des pulpites ou inflammation aiguë du nerf de la dent. En cas de pulpite, la dévitalisation (retrait du nerf) de la dent est la seule solution . Hydrogen sulfide has a destructive effect on the tissues exposed to it, leading to apoptotic death of periodontal cells. Moreover, it accelerates the proliferation of bone-destructive cells (osteoclasts) that can be concretely translated into bone resorption problems leading to periodontal disease or loosening. A vicious circle then engages because loosening is a common cause of halitosis. Hydrogen sulfide is also harmful to pulp cells, a recent study (Kobayashi et al., 2011, Journal of Endodontics, vol 37 (4): 4479-4484) shows that this hydrogen sulphide profoundly affects the metabolism of mitochondrial membranes of cells of the dental pulp causing apoptotic cell death. Located in a cavity in the center of the tooth, the pulp is however not isolated from the outside because exchanges occur permanently through the dentine, porous tissue, and the enamel that behaves as a selective membrane. Hydrogen sulfide penetrates and diffuses through the hard tissue of the tooth to affect its vitality. This phenomenon could explain the appearance of pulpites or acute inflammation of the nerve of the tooth. In case of pulpitis, the devitalization (removal of the nerve) of the tooth is the only solution.
Si les personnes souffrant d'halitose risquent de perdre leurs dents, à la fois par déchaussement et par dévitalisation, elles risquent des problèmes de santé bien plus conséquents. En effet, certains composés responsables de la mauvaise haleine (putrescine, cadavérine) sont des facteurs de croissance, impliqués dans le développement de tumeurs cancéreuses.  If people with halitosis risk losing their teeth, both by loosening and devitalization, they risk health problems much more consequent. Indeed, some compounds responsible for bad breath (putrescine, cadaverine) are growth factors, involved in the development of cancerous tumors.
La cause principale de l'halitose étant bien connue, il peut paraître simple de la combattre. On peut imaginer que le renforcement de l'hygiène est un remède efficace. L'utilisation d'antiseptiques réputés actifs dans le domaine bucco-dentaire devrait permettre d'éradiquer les bactéries responsables, mais leur localisation et leur faculté de colonisation et de croissance s'opposent à cette finalité. L'utilisation de solutions antiseptiques améliore l'état pathologique mais n'élimine pas totalement les causes. L'utilisation d'arômes mentholés masque transitoirement les mauvaises odeurs, mais cette action est fugace et l'extrême sensibilité olfactive des personnes rend ce concept aléatoire. Une autre méthode peut s'avérer utile et efficace, elle consiste à utiliser des molécules ou des extraits complexes réagissant avec les composés soufrés cités précédemment pour les rendre moins ou non volatiles. Ce sont essentiellement des sels de zinc, notamment des chlorures ou des lactates, des extraits de thé vert et certaines huiles essentielles. Le persil et le thé vert sont des plantes connues pour leurs propriétés antimicrobiennes. D'après une étude effectuée par Lodhia et al., 2008 (J. Nutr. Sci. Vitaminol. 54, 89-94), le thé vert permet de réduire la concentration en composés sulfures dans l'haleine buccale. De manière identique, les activités antibactériennes et anti infectieuses de l'huile essentielle de persil ont été décrites (El-Megeed Hashem and Farahat Sahab, 1999, Food chemistry 65, 29-33) . Par exemple, selon le brevet EP 1053743 l'association d'huile d'olive et d'huile de persil était revendiquée et selon la demande de brevet WO 2008/068408 il est revendiqué l'association d'huile essentielle de persil et d'extrait de thé vert, dans le traitement de l'halitose. Les principales revendications de cette demande concernent les quantités (exprimées en poids par rapport au poids total de la composition) respectives d'huile essentielle de persil (0,01% à 5%) et de thé vert (0,005% à 1%) et la composition selon cette invention est de préférence un sucre cuit ou une pastille à sucer. The main cause of halitosis being well known, it may seem simple to fight it. One can imagine that strengthening hygiene is an effective remedy. The use of antiseptics known to be active in the oral field should make it possible to eradicate the responsible bacteria, but their location and their ability to colonize and grow oppose this purpose. The use of antiseptic solutions improves the disease state but does not completely eliminate the causes. The use of menthol flavors transiently masks bad smells, but this action is fleeting and the extreme sensitivity of people makes this concept random. Another method may be useful and effective, it consists of using molecules or complex extracts reacting with the sulfur compounds mentioned above to make them less or nonvolatile. These are essentially zinc salts, especially chlorides or lactates, green tea extracts and some essential oils. Parsley and green tea are known for their antimicrobial properties. According to a study by Lodhia et al., 2008 (J. Nutr.Sci./ Vitaminol 54, 89-94), green tea makes it possible to reduce the concentration of sulfur compounds. in the mouth breath. Similarly, the antibacterial and anti-infectious activities of the parsley essential oil have been described (El-Megeed Hashem and Farahat Sahab, 1999, Food Chemistry 65, 29-33). For example, according to patent EP 1053743 the combination of olive oil and parsley oil was claimed and according to the patent application WO 2008/068408 it is claimed the combination of parsley essential oil and green tea extract, in the treatment of halitosis. The main claims of this application concern the quantities (expressed by weight relative to the total weight of the composition) of essential oil of parsley (0.01% to 5%) and green tea (0.005% to 1%) and the composition according to this invention is preferably a cooked sugar or a lozenge to be sucked.
Cependant ces formes galéniques peuvent poser des problèmes, les pastilles pouvant être avalées avant d'avoir complètement fondues et on retrouve alors les problèmes liés à l'ingestion de médicaments (étouffement, suffocation par obstruction de la gorge) . Par ailleurs, ces inconvénients peuvent être à l'origine de l'arrêt du traitement. Ces problèmes concernent en particulier les personnes âgés, les enfants, les patients atteints de troubles de la déglutition ou de pathologies affectant la sécrétion salivaire. Un autre inconvénient est le temps nécessaire pour que la pastille fonde complètement ce qui va à l' encontre de la discrétion que cherche le patient pour améliorer son haleine.  However these galenic forms can cause problems, the pellets can be swallowed before having completely melted and then we find the problems related to the ingestion of drugs (choking, suffocation by obstruction of the throat). Moreover, these disadvantages can be at the origin of the cessation of treatment. These problems particularly concern the elderly, children, patients with swallowing disorders or pathologies affecting salivary secretion. Another disadvantage is the time needed for the tablet to completely melt what goes against the discretion sought by the patient to improve his breath.
Les films à désintégration rapide doivent répondre à des conditions souvent contradictoires : ils doivent d'une part présenter un caractère liant leur permettant d'être mis en forme et, d'autre part, avoir une capacité de délitement quasi instantané. Ils doivent aussi présenter une souplesse et une résistance suffisantes, mais aussi une certaine stabilité nécessaire à des conditions normales de stockage. Ces qualités sont indispensables à leur conditionnement en sachets, en blisters ou en boîtes distributrices. Les films solubles actuellement utilisés sont principalement constitués de polymères hydrophiles ayant des propriétés filmogènes, et dont l'épaisseur et la surface spécifique permettent d'envisager une désintégration rapide au contact de la salive. Fast-disintegrating films must respond to often contradictory conditions: they must have a binding character that allows them to be shaped and, secondly, have an almost instant disintegration capability. They must also present sufficient flexibility and resistance, but also some stability necessary for normal storage conditions. These qualities are essential for their packaging in sachets, blisters or dispenser boxes. The currently used soluble films consist mainly of hydrophilic polymers having film-forming properties, and whose thickness and specific surface area make it possible to envisage rapid disintegration in contact with saliva.
Ces polymères hydrophiles filmogènes sont le plus souvent des glucanes, des gommes naturelles, ou des dérivés de povidone. La combinaison d'au moins deux polymères est généralement souhaitée afin de trouver un compromis entre les principales caractéristiques du film, c'est à dire la souplesse, la résistance mécanique et la vitesse de délitement .  These hydrophilic film-forming polymers are most often glucans, natural gums, or povidone derivatives. The combination of at least two polymers is generally desired in order to find a compromise between the main characteristics of the film, ie the flexibility, the mechanical strength and the speed of disintegration.
Ainsi, dans les films basés sur des polymères cellulosiques, l'association d'au moins deux polymères cellulosiques hydrosolubles est souvent nécessaire. Ceux comprenant l'association de polymères cellulosiques hydrosolubles de masse moléculaire élevée (60 000 à 150 000 Da) et de polymères cellulosiques hydrosolubles de masse moléculaire faible sont le plus souvent rencontrés. Le premier type de polymère permet de régler les propriétés mécaniques du film, tandis que le second type de polymère permet de faire varier le temps de désintégration.  Thus, in films based on cellulosic polymers, the combination of at least two water-soluble cellulosic polymers is often necessary. Those comprising the combination of water-soluble cellulosic polymers of high molecular weight (60,000 to 150,000 Da) and water-soluble cellulosic polymers of low molecular weight are most often encountered. The first type of polymer makes it possible to adjust the mechanical properties of the film, while the second type of polymer makes it possible to vary the disintegration time.
Par exemple, la demande internationale WO 05/039499 décrit une formulation de film pharmaceutique ou cosmétique à désintégration rapide et composée d'une combinaison de type hydroxypropylcellulose (Klucel JF®) et hydroxypropylméthylcellulose (Methocel® grades E, E50, E4M et SGA16M) . Toutefois, les films décrits dans cette demande contiennent chacun de nombreux agents plastifiants (polyalcools , ester de sorbitan, esters de l'acide citrique...) qui sont nécessaires à l'obtention de films flexibles et qui rendent la formulation complexe. For example, International Application WO 05/039499 discloses a fast disintegrating pharmaceutical or cosmetic film formulation consisting of a combination of hydroxypropylcellulose (Klucel JF®) and hydroxypropylmethylcellulose (Methocel® grades E, E50, E4M and SGA16M). However, the films described in this application each contain many plasticizers (polyalcohols, sorbitan ester, citric acid esters, etc.) which are necessary for obtaining flexible films and which make the formulation complex.
Par ailleurs, les polymères de type glucanes comme les pullulanes sont en théorie capables de former des films à désintégration rapide en raison de leur forte solubilité, de leur vitesse de dissolution rapide et de leurs propriétés gustatives. Cependant, leur faible masse moléculaire est un inconvénient qui a pour conséquence de ne pas faciliter la formation de films pour des concentrations inférieures à 20% ; en effet dans ces conditions, la viscosité des mélanges est faible et fait prendre un risque vis-à vis de l'homogénéité de ces derniers, quand, par exemple une charge insoluble (principe actif en dispersion) est ajoutée au mélange. Il est donc nécessaire d'associer aux pullulanes d'autres polymères naturels comme les carraghénates ou certaines gommes.  On the other hand, glucan polymers such as pullulans are theoretically capable of forming fast disintegrating films because of their high solubility, rapid dissolution rate and taste properties. However, their low molecular weight is a drawback which has the consequence of not facilitating the formation of films for concentrations of less than 20%; indeed, under these conditions, the viscosity of the mixtures is low and makes them take a risk with respect to the homogeneity of the latter, when, for example, an insoluble filler (active ingredient in dispersion) is added to the mixture. It is therefore necessary to associate pullulans with other natural polymers such as carrageenates or certain gums.
Ainsi la demande WO 03/030881 décrit une préparation, sous forme de film comestible comprenant de préférence un glucane et un polymère hydrosoluble, dans un rapport compris entre 40 : 1 et 0,5 : 1. Ce polymère hydrosoluble est caractérisé par une masse moléculaire élevée ce qui permet d'augmenter la viscosité naturellement faible des pullulanes et de stabiliser le mélange lorsqu' il comprend une suspension de principe actif. De préférence ce polymère est un polysaccharide ou une gomme naturelle, faisant partie des alginates, carraghénates, hydroxypropylméthylcellulose, gomme de caroube, gomme guar, gomme xanthane, dextrans, gomme arabique, gomme gellane, seuls ou en association. Toutefois les compositions décrites dans cette demande contiennent des agents anti¬ mousses, nécessaires à l'obtention de films dépourvus de bulles d'air. Il est aussi possible d'associer les polymères cellulosiques avec des polymères naturels comme les carraghénates ou certaines gommes. Ainsi, la demande internationale WO 04/105758 décrit une préparation polymérique ternaire, sous forme de film comestible à libération rapide contenant de la triprolidine destinée au traitement des troubles du sommeil, et comprenant de la gomme de xanthane, de 1 ' hydroxypropylméthylcellulose et du carraghénate . Thus, the application WO 03/030881 describes a preparation, in the form of an edible film preferably comprising a glucan and a water-soluble polymer, in a ratio of between 40: 1 and 0.5: 1. This water-soluble polymer is characterized by a molecular weight This makes it possible to increase the naturally low viscosity of the pullulans and to stabilize the mixture when it comprises a suspension of active principle. Preferably this polymer is a polysaccharide or a natural gum, forming part of alginates, carrageenates, hydroxypropylmethylcellulose, locust bean gum, guar gum, xanthan gum, dextrans, gum arabic, gellan gum, alone or in combination. However the compositions described in this application contain anti ¬ agents foams, necessary for obtaining films free of air bubbles. It is also possible to associate the cellulosic polymers with natural polymers such as carrageenates or certain gums. Thus, the international application WO 04/105758 describes a ternary polymeric preparation, in the form of fast release edible film containing triprolidine for the treatment of sleep disorders, and comprising xanthan gum, hydroxypropyl methylcellulose and carrageenan. .
Les gommes naturelles (gomme guar, gomme de caroube, gomme xanthane, alginates et carraghénates) ou la polyvinyle pyrrolidone sont souvent considérées comme des polymères stabilisants, qu'il est nécessaire d'ajouter soit aux dérivés cellulosiques, soit aux glucanes pour permettre la réalisation de films. Ces conditions ne sont pas toujours satisfaisantes, ce qui conduit là aussi à recourir à l'ajout d'un composé plastifiant, comme les esters polyoxyéthylénés de sorbitan, les esters d' acides gras et de glycérol, le glycérol, les esters d'acides gras et de propylène glycol, le propylène glycol, le dibutylsébacate, la triacétine.  Natural gums (guar gum, locust bean gum, xanthan gum, alginates and carrageenans) or polyvinyl pyrrolidone are often considered as stabilizing polymers, which must be added to either cellulose derivatives or glucans to enable the production of movies. These conditions are not always satisfactory, which also leads to the use of the addition of a plasticizer compound, such as polyoxyethylenated esters of sorbitan, esters of fatty acids and glycerol, glycerol, acid esters. fatty and propylene glycol, propylene glycol, dibutyl sebacate, triacetin.
Enfin, de nombreuses demandes sont caractérisées par la présence d'un nombre important de constituants. Ainsi, la demande internationale WO 03/030883 décrit une préparation sous forme de film comestible basée sur la combinaison complexe d' hydroxypropylméthylcellulose Finally, many applications are characterized by the presence of a large number of constituents. Thus, the international application WO 03/030883 describes a preparation in the form of an edible film based on the complex combination of hydroxypropylmethylcellulose.
(Methocel E15®) , de polyvinyle pyrrolidone, d'amidon de maïs (Pure cote B792®) , de gomme xanthane, de surfactant (Cremophor EL®), de plastifiant (propylène glycol) et de préférence un agent masquant le goût. (Methocel E15®), polyvinyl pyrrolidone, corn starch (Pure B792® grade), xanthan gum, surfactant (Cremophor EL®), plasticizer (propylene glycol) and preferably a taste-masking agent.
La demande internationale WO 98/20862 décrit un film à libération immédiate destiné à l'administration orale de principes actifs médicamenteux ou cosmétiques, composé de polymères hydrosolubles , d'un ou plusieurs polyalcools, de plastifiants, de surfactants, d'aromatisants et de colorants. De préférence les polymères sont des dérivés cellulosiques hydrosolubles , commeInternational Application WO 98/20862 discloses an immediate release film for the oral administration of medicinal or cosmetic active principles, composed of water-soluble polymers, one or more polyalcohols, plasticizers, surfactants, flavorings and dyes. Preferably, the polymers are water-soluble cellulosic derivatives, such as
1' hydroxypropylméthylcellulose, 1 ' hydroxyéthylcellulose et 1' hydroxypropylcellulose, seuls ou en association. Dans le film sec, la concentration en polymère cellulosique est comprise entre 20 et 75% en masse. D'autres polymères non cellulosiques peuvent également être mis en œuvre comme la polyvinyle pyrrolidone, la carboxyméthyle cellulose, l'alcool polyvinylique, l'alginate de sodium, le polyéthylèneglycol , les gommes naturelles comme la gomme xanthane, la gomme adragante, la gomme guar, la gomme d'acacia, la gomme arabique, les polyacrylates hydrodispersibles comme l'acide polyacrylique, le copolymère méthyleméthacrylate, les copolymères carboxyvinyliques . Hydroxypropyl methylcellulose, hydroxyethylcellulose and hydroxypropylcellulose, alone or in combination. In the dry film, the concentration of cellulosic polymer is between 20 and 75% by weight. Other non-cellulosic polymers can also be used, such as polyvinyl pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, polyethylene glycol, natural gums such as xanthan gum, gum tragacanth, guar gum acacia gum, gum arabic, water-dispersible polyacrylates such as polyacrylic acid, methylmethacrylate copolymer, carboxyvinyl copolymers.
La demande internationale WO 04/087084 décrit une préparation, sous forme de film comestible à libération rapide composée de polymères filmogènes cellulosiques, plus particulièrement d'un mélange de polymères à forte viscosité et de polymères à faible viscosité présents à faible concentration, ce qui présente un avantage économique. Les polymères cellulosiques sont de type hydroxypropylméthylcellulose, de préférence les produits Méthocel®, de la série K ou de la série E, et plus spécifiquement les grades K4M, K100, K3, E50 et E4M. Ici encore, la présence d'agents plastifiants, dans des proportions allant de 0,01% à 30%, est nécessaire à l'obtention de films flexibles et non cassants.  The international application WO 04/087084 describes a preparation, in the form of a fast release edible film composed of cellulosic film-forming polymers, more particularly of a mixture of high-viscosity polymers and low-viscosity polymers present at low concentration, which presents an economic advantage. The cellulosic polymers are of the hydroxypropyl methylcellulose type, preferably the Methocel®, K-series or E-series products, and more specifically the K4M, K100, K3, E50 and E4M grades. Here again, the presence of plasticizing agents, in proportions ranging from 0.01% to 30%, is necessary to obtain flexible and non-brittle films.
La demande internationale WO 04/045537 décrit une préparation complexe sous forme de film comestible destiné au traitement de la pharyngite, constituée de pullulanes, de gomme guar, de pectines, de gomme xanthane, d'alginates, de gélatine, d'amidons, d'amidons modifiés, de maltodextrines , de gluten, de carboxyméthylcellulose, de gomme de caroube, de carraghénates . The international application WO 04/045537 describes a complex preparation in the form of an edible film intended for the treatment of pharyngitis, consisting of pullulans, guar gum, pectins, xanthan gum, alginates, of gelatin, starches, modified starches, maltodextrins, gluten, carboxymethylcellulose, locust bean gum, carrageenates.
Enfin la demande internationale WO 08/107301 décrit des films monocouche à désintégration rapide dont la matrice est constituée essentiellement de deux polymères hydrosolubles . L'avantage de ces films réside dans le fait qu'ils sont dépourvus de plastifiant tout en restant suffisamment déformables sans être cassants. Les plastifiants étant souvent hygroscopiques, rendant délicate la conservation et la manipulation des films obtenus. Le film comprend un mélange polymérique d'un agent filmogène hydrophile constitué par un copolymère d'alcool polyvinylique et de polyéthylène glycol, d'une substance active et d'un agent hydrophile gélifiant.  Finally, international application WO 08/107301 describes fast disintegrating monolayer films whose matrix consists essentially of two water-soluble polymers. The advantage of these films lies in the fact that they are devoid of plasticizer while remaining sufficiently deformable without being brittle. The plasticizers are often hygroscopic, making the preservation and handling of the films obtained difficult. The film comprises a polymeric mixture of a hydrophilic film-forming agent consisting of a copolymer of polyvinyl alcohol and polyethylene glycol, an active substance and a hydrophilic gelling agent.
Il apparaît donc clairement que l'état de la technique fait référence à des compositions complexes. Il est donc nécessaire de concevoir un film comestible à désintégration rapide ayant une formulation simplifiée et qui présente des propriétés rhéologiques (souplesse, résistance mécanique et vitesse de délitement) équivalentes ou améliorées par rapport à l'art antérieur. Mais le film doit aussi être compatible avec l'extrait de thé vert, ingrédient riche en phénols pouvant limiter la compatibilité avec des polymères.  It therefore clearly appears that the state of the art refers to complex compositions. It is therefore necessary to design a rapidly disintegrating edible film having a simplified formulation and having rheological properties (flexibility, mechanical strength and disintegration speed) equivalent or improved over the prior art. But the film must also be compatible with green tea extract, a phenol-rich ingredient that can limit compatibility with polymers.
L'objet de la présente invention est de proposer de nouveaux films monocouche à désintégration rapide à base d'extrait de thé vert et d'huile essentielle de persil, tels que décrits ci-après et illustrés dans les exemples, dont la matrice est constituée essentiellement de deux polymères hydrosolubles. On entend par film à désintégration rapide, des formes galéniques souples d'une épaisseur inférieure à 100 microns et dont le temps de délitement, dissolution, dispersion ou décomposition dans la cavité buccale reste inférieur à une minute, avantageusement inférieur à 30 secondes et encore plus avantageusement de 10 à 20 secondes. Les substances actives contenues dans ce film peuvent ainsi être absorbées par passage de la muqueuse buccale ou sublinguale ou par déglutition . The object of the present invention is to provide novel fast disintegrating monolayer films based on green tea extract and parsley essential oil, as described below and illustrated in the examples, whose matrix is constituted essentially two water-soluble polymers. By fast-disintegrating film is meant flexible galenic forms having a thickness of less than 100 microns and whose disintegration, dissolution, dispersion or decomposition time in the oral cavity remains less than one minute, advantageously less than 30 seconds and even more advantageously from 10 to 20 seconds. The active substances contained in this film can thus be absorbed by passage of the oral mucosa or sublingual or by swallowing.
Au sens de la présente invention, les quantités d'extrait de thé vert dans la composition sont exprimées en poids d' extrait sec de thé vert par rapport au poids total de ladite composition.  For the purposes of the present invention, the amounts of green tea extract in the composition are expressed by weight of dry extract of green tea relative to the total weight of said composition.
Par « huile essentielle de persil », il faut entendre au sens de la présente invention l'huile essentielle obtenue à partir de feuilles et/ou de tiges de persil.  For the purposes of the present invention, the term "parsley essential oil" is intended to mean the essential oil obtained from leaves and / or stalks of parsley.
Préférentiellement , la quantité la quantité d'extrait de thé vert est comprise entre 1 et 15%, encore plus préférentiellement comprise entre 8 et 12% et encore plus préférentiellement est égale à 10%.  Preferably, the amount of green tea extract is between 1 and 15%, more preferably between 8 and 12% and even more preferably is equal to 10%.
Avantageusement, la quantité d'huile essentielle de persil est comprise entre 0,05 et 1%, encore plus avantageusement comprise entre 0,1 et 0,4% et encore plus avantageusement est égale à 0,3%.  Advantageously, the amount of parsley essential oil is between 0.05 and 1%, more advantageously between 0.1 and 0.4% and even more advantageously is equal to 0.3%.
La présente invention concerne donc un film monocouche à désintégration rapide pour l'administration buccale d'une composition à base d'extrait de thé vert et d'huile essentielle de persil, caractérisé en ce qu'il comprend un mélange de polymères hydrosolubles , d'un émulsionnant , et d'au moins un plastifiant.  The present invention thus relates to a monolayer film with rapid disintegration for the oral administration of a composition based on green tea extract and parsley essential oil, characterized in that it comprises a mixture of water-soluble polymers, d an emulsifier, and at least one plasticizer.
D'une manière préférée, le mélange de polymères hydrosolubles est constitué de carboxyméthylcellulose de sodium et d' hydroxypropylcellulose . Avantageusement, le ratio massique de carboxyméthylcellulose de sodium et d' hydroxypropylcellulose est compris entre 2 et 10, d'une manière plus avantageuse ce ratio est compris entre 3 et 5 et d'une manière encore plus avantageuse ce ratio est égal à 4. In a preferred manner, the mixture of water-soluble polymers consists of sodium carboxymethylcellulose and hydroxypropylcellulose. Advantageously, the weight ratio of sodium carboxymethylcellulose and hydroxypropylcellulose is between 2 and 10, more advantageously this ratio is between 3 and 5 and even more advantageously this ratio is equal to 4.
Le plastifiant permet d'augmenter la flexibilité des films, on peut citer par exemple les polyols, les esters de sorbitan, les esters d'acide citrique. Les plastifiants peuvent être ajoutés directement à la formulation pendant la fabrication des films. Les plastifiants convenables incluent le polyéthylène glycol, tel que le Lutrol E400, l'oxide de polyéthylène, les polyoxamères , l'alcool polyvinylique, ou des mélanges de ces polymères ; la triacétine, le glycérol, le mannitol, le xylitol et d'autres polyols bien connus de l'homme du métier. Le sorbitol et le glycérol sont particulièrement bien adaptés. Les quantités de plastifiants dans la présente invention sont comprises entre 0,5 et 10% en poids du film sec, et plus particulièrement entre 2 et 4%.  The plasticizer makes it possible to increase the flexibility of the films, for example polyols, sorbitan esters or citric acid esters. The plasticizers can be added directly to the formulation during the manufacture of the films. Suitable plasticizers include polyethylene glycol, such as Lutrol E400, polyethylene oxide, polyoxamers, polyvinyl alcohol, or mixtures of these polymers; triacetin, glycerol, mannitol, xylitol and other polyols well known to those skilled in the art. Sorbitol and glycerol are particularly well suited. The amounts of plasticizers in the present invention are between 0.5 and 10% by weight of the dry film, and more particularly between 2 and 4%.
Le mélange homogène contient en outre des composants additionnels comme un ou plusieurs émulsionnant ( s ) et/ou un plusieurs agent (s) de charge. Les émulsionnants préférés sont les esters de sucre, que l'homme du métier connaît bien. On citera comme émulsionnant préféré le stéarate de sucrose. Il est important de noter que le polysorbate 80 (également appelé « tween 80 ») à 1% et le polyéthylèneglycol à 4% n'ont pas permis de rendre le mélange suffisamment homogène aux concentrations testées, révélant la difficulté technique pour obtenir une formulation adéquate. En effet, l'ajout de Tween 80 à 1% comme émulsionnant est responsable de la présence sur les films du phénomène de « fish eyes », cet émulsionnant n'a pas permis d'améliorer le résultat. D'autres essais ont été réalisés en prenant comme émulsionnant le polyéthylène glycol 40 à 4%, le produit s'est révélé stable, sans précipité mais lors des études de stabilité, il s'est avéré que les films collaient entre eux, cet émulsionnant a donc également été écarté. Enfin les études menées avec le stéarate de sucrose comme émulsionnant ont été concluantes. The homogeneous mixture further contains additional components such as one or more emulsifier (s) and / or a plurality of filler (s). The preferred emulsifiers are sugar esters, which the skilled person knows well. The preferred emulsifier is sucrose stearate. It is important to note that polysorbate 80 (also called "tween 80") at 1% and polyethylene glycol at 4% did not make the mixture sufficiently homogeneous at the concentrations tested, revealing the technical difficulty to obtain an adequate formulation . Indeed, the addition of Tween 80 at 1% as an emulsifier is responsible for the presence on the films of the phenomenon of "fish eyes", this emulsifier has not allowed to improve the result. Other tests were carried out by taking as emulsifier polyethylene glycol 40 at 4%, the product was found to be stable, without precipitate, but in stability studies, it was found that the films stick together, this emulsifier has also been ruled out. Finally, the studies conducted with sucrose stearate as an emulsifier were conclusive.
L'agent de charge peut être choisi parmi les charges minérales classiquement utilisées telles que la silice, le talc ou autre silicate, le dioxyde de titane, mais également parmi certains diluants ou lubrifiants pharmaceutiques tels que les stéarates de magnésium, de calcium, ou de zinc.  The filler may be chosen from the mineral fillers conventionally used, such as silica, talc or other silicate, titanium dioxide, but also from certain pharmaceutical diluents or lubricants such as magnesium stearates, calcium stearates, or zinc.
Des composés optionnels additionnels peuvent être ajoutés selon l'invention. Par exemple, des arômes et/ou des édulcorants peuvent être additionnés à la formulation des films afin d'améliorer la palatabilité des films. Les arômes, les édulcorants peuvent être ajoutés lors de la fabrication des films. Ils peuvent être naturels ou artificiels, ils sont bien connus de l'homme du métier. Le choix des arômes et/ou des édulcorants n'est pas important pour l'invention.  Additional optional compounds may be added according to the invention. For example, flavors and / or sweeteners may be added to the film formulation to improve the palatability of the films. Aromas and sweeteners can be added during the production of films. They can be natural or artificial, they are well known to those skilled in the art. The choice of flavors and / or sweeteners is not important for the invention.
L'invention concerne aussi l'utilisation d'une composition d'hygiène buccale sous forme de film monocouche à désintégration rapide comprenant un extrait de thé vert, de l'huile essentielle de persil, un mélange de polymères hydrosolubles , un émulsionnant, et au moins un plastifiant pour la préparation d'un médicament destiné à prévenir et/ou traiter l'halitose.  The invention also relates to the use of an oral hygiene composition in the form of a fast disintegrating monolayer film comprising a green tea extract, parsley essential oil, a mixture of water-soluble polymers, an emulsifier, and less a plasticizer for the preparation of a medicament for preventing and / or treating halitosis.
L' invention va maintenant être illustrée à titre non limitatif par les exemples suivants. Ces exemples mettent particulièrement en relief la difficulté de la mise au point de la composition. Exemple 1 The invention will now be illustrated by way of non-limiting example by the following examples. These examples particularly highlight the difficulty of developing the composition. Example 1
Dans cet exemple, plusieurs axes de formulations (Tableau 1) ont été initiés de manière à sélectionner un ou plusieurs polymères de statut alimentaire, caractérisés par leurs propriétés filmogènes mais aussi par leur compatibilité avec l'extrait sec de thé vert, en effet la richesse en phénols de cet ingrédient peut en limiter la compatibilité .  In this example, several axes of formulations (Table 1) were initiated so as to select one or more polymers of food status, characterized by their film-forming properties but also by their compatibility with the dry extract of green tea, indeed the wealth in phenols of this ingredient may limit its compatibility.
Tableau 1, compatibilité de différents polymères de statut alimentaire avec l'extrait sec de thé vert  Table 1, compatibility of different food grade polymers with dry extract of green tea
Figure imgf000014_0001
Figure imgf000014_0001
ES TV : extrait sec de thé vert ; AP : amidon de pois ; CMC : carboxyméthylcellulose ; HPC : hydroxypropylméthylcellulose ; MC : méthylcellulose ; P : pectine ; PVP : polyvinylpyrrolidone . Les essais réalisés en associant le Klucel Nutra W (hydroxypropylcellulose) et le Blanose 7LFES TV: dry extract of green tea; AP: pea starch; CMC: carboxymethylcellulose; HPC: hydroxypropyl methylcellulose; MC: methylcellulose; P: pectin; PVP: polyvinylpyrrolidone. Tests carried out by combining Klucel Nutra W (hydroxypropylcellulose) and Blanose 7LF
( carboxyméthylcellulose de sodium) sont les plus satisfaisants. En effet, ils permettent d'obtenir un film pas trop cassant et ses propriétés mécaniques sont particulièrement adaptées aux contraintes de procédés des différentes étapes de refente, de découpe et de mise en boîte . (sodium carboxymethylcellulose) are the most satisfactory. In fact, they make it possible to obtain a film which is not too brittle and its mechanical properties are particularly adapted to the process constraints of the various stages of slitting, cutting and canning.
Exemple 2 Example 2
Dans cet exemple, de nombreux essais ont été réalisés pour comparer l'influence de charge soluble (sorbitol) ou insoluble (dioxyde de titane) sur le délitement du film ainsi que sur ses propriétés mécaniques et ce pour des ratios différents entre les polymères.  In this example, numerous attempts have been made to compare the influence of soluble filler (sorbitol) or insoluble (titanium dioxide) on the disintegration of the film as well as on its mechanical properties and for different ratios between the polymers.
Les caractéristiques du film à savoir sa transparence, sa souplesse, sa résistance, s'il est bruyant ou non, s'il est collant, élastique ont été évaluées. D'autres paramètres comme le grammage, le temps de désintégration, la force maximale et l'allongement à la rupture ont également été quantifiés. Plusieurs concentrations de sorbitol en présence ou non de dioxyde de titane ont été évaluées en faisant également varier les ratios entre le carboxyméthylcellulose de sodium et l' hydroxypropylcellulose .  The characteristics of the film namely its transparency, its flexibility, its resistance, whether it is noisy or not, if it is sticky, elastic have been evaluated. Other parameters such as grammage, disintegration time, maximum force and elongation at break have also been quantified. Several concentrations of sorbitol in the presence or absence of titanium dioxide were evaluated by also varying the ratios between sodium carboxymethylcellulose and hydroxypropylcellulose.
II ressort de toutes ces expériences qu'un ratio carboxyméthylcellulose de sodium / hydroxypropylcellulose de 80/20 est finalement choisi ainsi qu'un grammage de 80 g/m2. All these experiments show that a ratio of 80/20 sodium carboxymethylcellulose / hydroxypropylcellulose is finally chosen as well as a basis weight of 80 g / m 2 .
Exemple 3 Example 3
Principales caractéristiques d'un film à désintégration rapide qui a donné des résultats particulièrement satisfaisants. Tableau 2 Main features of a fast disintegrating film which gave particularly satisfactory results. Table 2
Moyenne Average
Surface (cm2) 6, 5Area (cm 2 ) 6, 5
Epaisseur (μπι) 54Thickness (μπι) 54
Désintégration (s) 14,3Decay (s) 14.3
Perte à la dessiccation (%) 15 Loss on drying (%) 15
Force max (MPa) 61,7 Max Force (MPa) 61.7
Test de traction Allongement à la rupture (%) 7,3 Tensile test Elongation at break (%) 7.3
Exemple 4, exemples de compositions selon l'invention Composition unitaire d'un film à désintégration (Tableau 3) . EXAMPLE 4 Examples of Compositions According to the Invention Unit Composition of a Disintegrating Film (Table 3).
Matière première mg/unité % m/m Raw material mg / unit% m / m
Carboxyméthylcellulose de sodium 27, 82 65, 5  Sodium carboxymethylcellulose 27, 82 65, 5
Hydroxypropylcellulose 6, 95 16,4  Hydroxypropylcellulose 6, 95 16.4
Extrait de thé vert 4, 14 9,7  Green tea extract 4, 14 9.7
Huile essentielle de persil 0, 13 0,3  Parsley essential oil 0, 13 0.3
Glycérol 0, 93 2,2  Glycerol 0, 93 2.2
Sorbitol 0,31 0,7  Sorbitol 0.31 0.7
Sucrose stéarate 0,44 1,0  Sucrose stearate 0.44 1.0
Sucralose 0, 04 0, 09  Sucralose 0, 04 0, 09
Saccharine sodique 0, 02 0, 05  Saccharin sodium 0, 02 0, 05
Eau Qsp  Water Qsp
Total 44 100 Autre composition unitaire d'un film à désintégration rapide (Tableau 4) . Total 44,100 Another unitary composition of a fast disintegrating film (Table 4).
Matière première mg/unité % m/m  Raw material mg / unit% m / m
Carboxyméthylcellulose de sodium 27, 82 65, 5  Sodium carboxymethylcellulose 27, 82 65, 5
Hydroxypropylcellulose 6, 95 16,4  Hydroxypropylcellulose 6, 95 16.4
Extrait de thé vert 4, 14 9,7  Green tea extract 4, 14 9.7
Huile essentielle de persil 0, 08 0,2  Parsley essential oil 0, 08 0,2
Glycérol 0, 93 2,2  Glycerol 0, 93 2.2
Sorbitol 0,31 0,7  Sorbitol 0.31 0.7
Sucrose stéarate 0,44 1,0  Sucrose stearate 0.44 1.0
Sucralose 0, 04 0, 09  Sucralose 0, 04 0, 09
Saccharine sodique 0, 02 0, 05  Saccharin sodium 0, 02 0, 05
Acesulfam potassium 0, 02 0, 05  Acesulfam potassium 0, 02 0, 05
Chlorophylline cupro sodique 0, 10 0,2  Chlorophylline cupro sodium 0, 10 0.2
Eau Qsp  Water Qsp
Total 44 100 Total 44,100

Claims

Revendications claims
1. Film monocouche à désintégration rapide pour l'administration buccale d'une composition à base d'extrait de thé vert et d'huile essentielle de persil, caractérisé en ce qu' il comprend un mélange de polymères hydrosolubles constitué de carboxyméthylcellulose de sodium et d' hydroxypropylcellulose, d'un émulsionnant , et d'au moins un plastifiant. A rapidly disintegrating monolayer film for oral administration of a composition based on green tea extract and parsley essential oil, characterized in that it comprises a mixture of water-soluble polymers consisting of sodium carboxymethylcellulose and hydroxypropylcellulose, an emulsifier, and at least one plasticizer.
2. Film selon la revendication 1, caractérisé en ce que le ratio massique de carboxyméthylcellulose de sodium / hydroxypropylcellulose est compris entre 2 et 10. 2. Film according to claim 1, characterized in that the mass ratio of sodium carboxymethylcellulose / hydroxypropylcellulose is between 2 and 10.
3. Film selon la revendication 1, caractérisé en ce que le ratio massique de carboxyméthylcellulose de sodium / hydroxypropylcellulose est compris entre 3 et 5.  3. Film according to claim 1, characterized in that the mass ratio of sodium carboxymethylcellulose / hydroxypropylcellulose is between 3 and 5.
4. Film selon la revendication 1, caractérisé en ce que le ratio massique de carboxyméthylcellulose de sodium / hydroxypropylcellulose est égal à 4.  4. Film according to claim 1, characterized in that the mass ratio of sodium carboxymethylcellulose / hydroxypropylcellulose is equal to 4.
5. Film selon l'une quelconque des revendications 1 à 4, caractérisé en ce que les quantités d'extrait de thé vert et d'huile essentielle de persil sont respectivement comprises entre 1 et 15% et entre 0,05 à 1% en poids par rapport au poids total de la composition.  5. Film according to any one of claims 1 to 4, characterized in that the amounts of green tea extract and parsley essential oil are respectively between 1 and 15% and between 0.05 to 1% by weight. weight relative to the total weight of the composition.
6. Film selon l'une quelconque des revendications 1 à 4, caractérisé en ce que les quantités d'extrait de thé vert et d'huile essentielle de persil sont respectivement comprises entre 8 et 12% et entre 0,1 à 0,4% en poids par rapport au poids total de la composition.  6. Film according to any one of claims 1 to 4, characterized in that the amounts of green tea extract and parsley essential oil are respectively between 8 and 12% and between 0.1 to 0.4 % by weight relative to the total weight of the composition.
7. Film selon l'une quelconque des revendications 1 à 4, caractérisé en ce que les quantités d'extrait de thé vert et d'huile essentielle de persil sont respectivement de 10% et de 0,3%. 7. Film according to any one of claims 1 to 4, characterized in that the amounts of green tea extract and parsley essential oil are respectively 10% and 0.3%.
8. Utilisation d'une composition d'hygiène buccale sous forme de film monocouche à désintégration rapide comprenant un extrait de thé vert, de l'huile essentielle de persil, un mélange de polymères hydrosolubles constitué de carboxyméthylcellulose de sodium et d' hydroxypropylcellulose, un émulsionnant , et au moins un plastifiant pour la préparation d'un médicament destiné à prévenir et/ou traiter l'halitose. 8. Use of an oral hygiene composition in the form of a fast-disintegrating monolayer film comprising a green tea extract, parsley essential oil, a mixture of water-soluble polymers consisting of sodium carboxymethylcellulose and hydroxypropylcellulose, a emulsifier, and at least one plasticizer for the preparation of a medicament for preventing and / or treating halitosis.
9. Utilisation selon la revendication 8, caractérisée en ce que le ratio massique de carboxyméthylcellulose de sodium / hydroxypropylcellulose est compris entre 2 et 10.  9. Use according to claim 8, characterized in that the mass ratio of sodium carboxymethylcellulose / hydroxypropylcellulose is between 2 and 10.
10. Utilisation selon la revendication 8, caractérisée en ce que le ratio massique de carboxyméthylcellulose de sodium / hydroxypropylcellulose est compris entre 3 et 5.  10. Use according to claim 8, characterized in that the mass ratio of sodium carboxymethylcellulose / hydroxypropylcellulose is between 3 and 5.
11. Utilisation selon la revendication 8, caractérisée en ce que le ratio massique de carboxyméthylcellulose de sodium / hydroxypropylcellulose est égal à 4. 11. Use according to claim 8, characterized in that the mass ratio of sodium carboxymethylcellulose / hydroxypropylcellulose is equal to 4.
12. Utilisation selon l'une quelconque des revendications 8 à 11, caractérisée en ce que les quantités d'extrait de thé vert et d'huile essentielle de persil sont respectivement comprises entre 1 et 15% et entre 0,05 à 1% en poids par rapport au poids total de la composition.  12. Use according to any one of claims 8 to 11, characterized in that the amounts of green tea extract and parsley essential oil are respectively between 1 and 15% and between 0.05 to 1% by weight. weight relative to the total weight of the composition.
13. Utilisation selon l'une quelconque des revendications 8 à 11, caractérisée en ce que les quantités d'extrait de thé vert et d'huile essentielle de persil sont respectivement comprises entre 8 et 12% et entre 0,1 à 0,4% en poids par rapport au poids total de la composition.  13. Use according to any one of claims 8 to 11, characterized in that the amounts of green tea extract and parsley essential oil are respectively between 8 and 12% and between 0.1 to 0.4 % by weight relative to the total weight of the composition.
14. Utilisation selon l'une quelconque des revendications 8 à 11, caractérisée en ce que les quantités d'extrait de thé vert et d'huile essentielle de persil sont respectivement de 10% et de 0,3%.  14. Use according to any one of claims 8 to 11, characterized in that the amounts of green tea extract and parsley essential oil are respectively 10% and 0.3%.
PCT/EP2013/059748 2012-05-11 2013-05-10 Rapidly disintegrating monolayer film and use thereof in oral hygiene WO2013167742A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1254325A FR2990349B1 (en) 2012-05-11 2012-05-11 FAST DISINTEGRATING MONOLAYER FILM AND ITS USE IN ORAL HYGIENE
FR1254325 2012-05-11

Publications (1)

Publication Number Publication Date
WO2013167742A1 true WO2013167742A1 (en) 2013-11-14

Family

ID=48407574

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/059748 WO2013167742A1 (en) 2012-05-11 2013-05-10 Rapidly disintegrating monolayer film and use thereof in oral hygiene

Country Status (2)

Country Link
FR (1) FR2990349B1 (en)
WO (1) WO2013167742A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019198109A1 (en) * 2018-04-13 2019-10-17 Zim Laboratories Limited Novel pharmaceutical composition of essential oil

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020862A1 (en) 1996-11-11 1998-05-22 Lts Lohmann Therapie-Systeme Gmbh Immediate wettability water soluble film or water soluble layer for oral application
EP1053743A1 (en) 1998-02-06 2000-11-22 Biocosmetics, S.L. Composition for the treatment of halitosis
WO2003030881A1 (en) 2001-10-12 2003-04-17 Kosmos Pharma Glucan based film delivery systems
WO2003030883A1 (en) 2001-10-12 2003-04-17 Kosmos Pharma Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
WO2004045537A2 (en) 2002-11-14 2004-06-03 Zengen, Inc. Edible film for relief of cough or symptoms associated with pharyngitis
WO2004087084A1 (en) 2003-03-26 2004-10-14 The Procter & Gamble Company Rapidly dissolving edible film compositions with cellulose film forming polymers
WO2004105758A1 (en) 2003-05-30 2004-12-09 The Boots Company Plc Use of tripolidine in providing refreshedness on waking
WO2005039499A2 (en) 2003-10-24 2005-05-06 Adhesives Research, Inc. Rapidly disintegrating film
WO2007030754A2 (en) * 2005-09-09 2007-03-15 Monosolrx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
WO2008068408A2 (en) 2006-11-13 2008-06-12 Pierre Fabre Medicament Oral hygiene composition and its use in the treatment of halitosis
WO2008107301A2 (en) 2007-02-28 2008-09-12 Pierre Fabre Medicament Rapid-disintegration monolayer film for the oral administration of active substances
WO2009045022A2 (en) * 2007-10-03 2009-04-09 C.L. Pharm Edible film
WO2010083227A1 (en) * 2009-01-14 2010-07-22 Nutrafood Nutrients, Inc. Consumable dissolving film comprising active ingredients derived from bacteria and fungi

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020862A1 (en) 1996-11-11 1998-05-22 Lts Lohmann Therapie-Systeme Gmbh Immediate wettability water soluble film or water soluble layer for oral application
EP1053743A1 (en) 1998-02-06 2000-11-22 Biocosmetics, S.L. Composition for the treatment of halitosis
WO2003030881A1 (en) 2001-10-12 2003-04-17 Kosmos Pharma Glucan based film delivery systems
WO2003030883A1 (en) 2001-10-12 2003-04-17 Kosmos Pharma Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
WO2004045537A2 (en) 2002-11-14 2004-06-03 Zengen, Inc. Edible film for relief of cough or symptoms associated with pharyngitis
WO2004087084A1 (en) 2003-03-26 2004-10-14 The Procter & Gamble Company Rapidly dissolving edible film compositions with cellulose film forming polymers
WO2004105758A1 (en) 2003-05-30 2004-12-09 The Boots Company Plc Use of tripolidine in providing refreshedness on waking
WO2005039499A2 (en) 2003-10-24 2005-05-06 Adhesives Research, Inc. Rapidly disintegrating film
WO2007030754A2 (en) * 2005-09-09 2007-03-15 Monosolrx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
WO2008068408A2 (en) 2006-11-13 2008-06-12 Pierre Fabre Medicament Oral hygiene composition and its use in the treatment of halitosis
WO2008107301A2 (en) 2007-02-28 2008-09-12 Pierre Fabre Medicament Rapid-disintegration monolayer film for the oral administration of active substances
WO2009045022A2 (en) * 2007-10-03 2009-04-09 C.L. Pharm Edible film
WO2010083227A1 (en) * 2009-01-14 2010-07-22 Nutrafood Nutrients, Inc. Consumable dissolving film comprising active ingredients derived from bacteria and fungi

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DIXIT R P ET AL: "Oral strip technology: Overview and future potential", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 139, no. 2, 15 October 2009 (2009-10-15), pages 94 - 107, XP026601268, ISSN: 0168-3659, [retrieved on 20090624], DOI: 10.1016/J.JCONREL.2009.06.014 *
EL-MEGEED HASHEM; FARAHAT SAHAB, FOOD CHEMISTRY, vol. 65, 1999, pages 29 - 33
KOBAYASHI ET AL., JOURNAL OF ENDODONTICS, vol. 37, no. 4, 2011, pages 4479 - 4484
LODHIA ET AL., J. NUTR. SCI. VITAMINOL., vol. 54, 2008, pages 89 - 94

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019198109A1 (en) * 2018-04-13 2019-10-17 Zim Laboratories Limited Novel pharmaceutical composition of essential oil

Also Published As

Publication number Publication date
FR2990349A1 (en) 2013-11-15
FR2990349B1 (en) 2014-08-08

Similar Documents

Publication Publication Date Title
JP6266075B2 (en) Edible oral strip or wafer dosage form containing ion exchange resin for taste masking
JP5213446B2 (en) Pharmaceutical composition comprising diclofenac
CA2193454C (en) Bioadhesive pharmaceutical composition for the controlled release of active ingredients
DE60210289T2 (en) BREATHTAKING FILM
TWI381854B (en) Phase transitive breath care product
TW201043253A (en) Dentifrice composition
FR2514642A1 (en) DELAYED RELEASE PHARMACEUTICAL COMPOSITIONS
EP2131823B9 (en) Rapid-disintegration monolayer film for the oral administration of active substances
EP2379173B1 (en) Anti-snoring composition containing a thermogelling polymer
WO2010015754A1 (en) Pharmaceutical composition in granule form and method for the production of such a pharmaceutcal composition
EP1807114B1 (en) Bioadhesive composition with programmed release
WO2013167742A1 (en) Rapidly disintegrating monolayer film and use thereof in oral hygiene
EP2745839A1 (en) Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum
WO2014020039A1 (en) Lozenges with multiple release kinetics for active ingredients
EP3752129B1 (en) Multi-use torasemide composition
EP3558267B1 (en) A mucoadhesive oromucosal formulation comprising a nicotine complex
FR3037799A1 (en) HYDRODISPERSIBLE SOLID PARTICLES BASED ON PROPOLIS
US20230330036A1 (en) Long acting, continuous oral release from oral dispersing strips (ods) addressing the need for high dosage of active ingredients
JP2024030812A (en) Oral film preparation
FR3124953A1 (en) Galenic form based on baobab pulp, methods of preparation and uses
FR3095762A1 (en) Solid composition for rapid ingestion and easy swallowing, in the form of non-agglomerated solid particles, comprising two different types of particles
WO2016055702A1 (en) Dermatological composition for the prevention and treatment of subcutaneous varicose veins
FR2890561A1 (en) Aqueous ophthalmic composition for treating cystinosis, comprises cysteamine salt and viscosifying agent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13721769

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13721769

Country of ref document: EP

Kind code of ref document: A1